首页> 外文期刊>Methods: A Companion to Methods in Enzymology >Animal models of type I allergy using recombinant allergens.
【24h】

Animal models of type I allergy using recombinant allergens.

机译:使用重组变应原的I型过敏动物模型。

获取原文
获取原文并翻译 | 示例
           

摘要

Various animal models including guinea pigs, monkeys, dogs, rats, and mice have been established in an attempt to provide insights into the complex immunological and pathophysiological mechanisms of human type I allergic diseases. The detailed knowledge of the murine genome, the various components of the murine immune system, and the generation of engineered mice has made the murine system the most attractive among all animal models. The availability of multitude technologies and reagents to characterize and manipulate immunological pathways and mediators adds to the outstanding opportunities to assess the pathology of allergic diseases and to develop novel therapeutic strategies in mice. Numerous sensitization protocols with food and aero-allergens are used to establish an allergic/asthma-like phenotype in mice. Requirements for an appropriate murine model include a close resemblance to the pathology of the disease in humans, the objective measurement of the physiologic parameters, as well as reliability and reproducibility of the experimental data. With respect to reproducible experimental conditions, it has been recognized that extract preparations from natural allergen sources can vary in their allergen-content and -composition. This might influence the degree of sensitization or the outcome of treatment strategies in dependence of the applied extract preparation. The use of recombinant allergens in experimental in vivo and in vitro systems can overcome these problems. Another aspect, that has become obvious from the experimental studies, is that allergens can differ in their immunogenicity as well as in their capacity to act as tolerogens. Therefore, it seems important that the efficacy of the different allergen-molecules to act as therapeutic agents is individually examined. In this review, examples of animal models are described, in which recombinant allergens have been used for sensitization and/or treatment of allergic responses and how they have been used to enhance our understanding of the pathology of allergic diseases.
机译:已经建立了包括豚鼠,猴子,狗,大鼠和小鼠在内的各种动物模型,以试图提供对人类I型变应性疾病的复杂免疫和病理生理机制的见解。对鼠基因组的详细了解,鼠免疫系统的各个组成部分以及工程小鼠的产生,使得鼠系统在所有动物模型中最有吸引力。表征和操纵免疫途径和介体的多种技术和试剂的可用性增加了评估变态反应性疾病的病理学并开发新的小鼠治疗策略的绝佳机会。与食物和空气过敏原有关的多种致敏方案可用于在小鼠中建立过敏/哮喘样表型。对合适的鼠模型的要求包括与人类疾病的病理极为相似,对生理参数的客观测量以及实验数据的可靠性和可重复性。关于可再现的实验条件,已经认识到,来自天然过敏原来源的提取物制剂的过敏原含量和组成可以变化。这可能会影响敏化程度或治疗策略的结果,具体取决于所应用的提取物制剂。在体内和体外实验系统中使用重组变应原可以克服这些问题。从实验研究中显而易见的另一个方面是,变应原的免疫原性以及其作为致耐受原的能力可能不同。因此,似乎很重要的一点是,分别检查不同的过敏原分子作为治疗剂的功效。在这篇综述中,描述了动物模型的例子,其中重组变应原已用于敏化和/或治疗变应性反应,以及如何将它们用于增强我们对变应性疾病病理学的理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号